Skip to main content
. 2015 Dec 10;13:21. doi: 10.1186/s12962-015-0046-8

Table 8.

25 % varying impact on TDF outcomes

Age HBeAg (−) rate (%) TDF: virologic response 48th week in HBeAg (−) (%) TDF: virologic response 48th week in HBeAg (+) (%) TDF annual drug cost (TL)
Base case 40 70 93.2 76.1 2236
25 % increase 50 88 100.0 95.2 2796
25 % decrease 30 53 69.9 57.1 1677